Global demand for over-the-counter drugs Market was valued at approximately USD 142.4 Billion in 2019, and is expected to generate revenue of around USD 223.5 Billion by end of 2026, growing at a CAGR of around 6.8% between 2020 and 2026
The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counter drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the over-the-counter drugs market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the over-the-counter drugs market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment is benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the over-the-counter drugs market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the over-the-counter drugs market on global and regional basis.
Global Over-the-Counter Drugs Market: By Product
Global Over-the-Counter Drugs Market: By Region
According to the report, global demand for over-the-counter drugs market was valued at approximately USD 142.4 Billion in 2019, and is expected to generate revenue of around USD 223.5 Billion by end of 2026, growing at a CAGR of around 6.8% between 2020 and 2026.
North America will be the foremost region during the estimate period. Ease of availability, sale of higher quality products and existence of top market players will enhance the market growth in this region. Europe will be the second largest market.
The report also includes detailed profiles of key players such as GlaxoSmithKline (GSK), Sun Pharmaceutical Industries Ltd., Bayer HealthCare, Johnson & Johnson, Pfizer, Sanofi, Alkem Laboratories Limited, Glenmark Pharmaceuticals Ltd., Cipla, Inc., Takeda, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc, Innovus Pharmaceutical Inc., Piramal, and Dr. Reddy's Laboratories among others.